Battersea Biotech Overview

  • Founded
  • 2016
  • Status
  • Out of Business
  • Latest Deal Type
  • Out of Business

Battersea Biotech General Information


Developer of cell therapies created to treat cancer. The company's therapies develop advanced techniques to overcome the shortcomings of current CAR-T and TCR technologies, thus enabling healthcare practitioners and organizations to provide proper treatment for cancer.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Primary Office
  • 1700 Owens Street
  • Suite 530
  • San Francisco, CA 94107
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Battersea Biotech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Out of Business 29-Dec-2017 Completed Out of Business
2. Accelerator/Incubator 12-Jul-2017 Completed Startup
1. Early Stage VC 21-Nov-2016 Completed Startup
To view Battersea Biotech’s complete valuation and funding history, request access »